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Abstract
Purpose—Most melanoma studies have been performed in the white population who exhibits the 
highest incidence rate due to their skin sensitivity to UV radiation. Previous publications have 
shown that young women (approximately under the menopausal age) exhibit higher incidence 
rates than men of the same age, and the causes are mostly attributed to their sun behavior or indoor 
tanning. In our recent publications, we suggested that higher risk in younger women was due to 
pathophysiological factors, such as hormonal impact, and thus this higher risk in young women 
should be shared across ethnicities regardless of their skin color or UV behavior.
Methods—A total of 13,208 non-white melanoma patients from SEER and 15,226 from WHO 
CI5-Plus were extracted for analysis. Age-specific incidence rates, female to male incidence rate 
ratios, and p-values were calculated.
Results—As observed in the white population, younger women and older men showed higher 
melanoma incidence rates than their peers of the other gender in all ethnic groups. The highest 
female to male incidence rate ratios were observed in the pubescent and reproductive ages. 
Previously this gender discrepancy in the white population was attributed to the preference of skin 
tanning in young females. There is no evidence to show that darker skinned young females adopt a 
similar tanning preference. Thus the age-dependent gender difference in the risk of melanoma is 
shared across ethnic groups and is perhaps independent of UV behavior.
Conclusions—Our results highlight the importance of gender as one of the melanoma risk 
factors beyond traditional UV radiation, which warrants further investigation and may provide a 
base for an improved prevention strategy.
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Introduction
Cutaneous melanoma has been considered as a UV radiation-driven malignancy [1–5]. 
Therefore, deciphering the mechanisms involved in UV-mediated melanoma formation and 
development has been the top priority in the field of melanoma prevention [6]. Because the 
white population exhibits the highest incidence rate compared with other ethnic groups [7], 
related etiological mechanisms have been extensively studied in this population. For 
example, the rich pheomelanin in the whites is found not only less effective in protecting 
skin stem cells [8], but also more prone to produce reactive oxygen species (ROS) upon UV 
stimulation [9]. The UV-broken melanin fragments are also found to diffuse along with ROS 
into the nucleus to induce DNA mutations, immunosuppression, and photoaging [5, 10]. All 
these factors had led to the importance of melanin-related oxidative stress in the 
photobiological cause of melanoma in the whites. Fewer studies were based on other ethnic 
groups.
Recently, new epidemiology study on melanoma gender differences discovered that sex 
might play an independent role in early onset melanoma, which may add expanded levels of 
understanding to our current UV-based melanomagenesis mechanism [11]. Overall 
incidence rates of men in all races in the US were higher than that of women [12]. However 
when stratified by age, women under age 50 showed higher incidence rates as compared to 
men of the same age; and the incidence rates switched after age 50 [13]. The highest female 
to male incidence rate ratio (RR) was found to be between age 20 and 24 years in the whites 
[14]. Our previous study suggested that other ethnic groups should have shown a similar 
age-dependent gender differences pattern [14]. Therefore, in this study, we focused on the 
gender difference in the non-white ethnic populations based on a hypothesis that young 
women are at higher risk of melanoma than young men in the same age range regardless of 
their race or skin color. This hypothesis argued for the importance of gender-related factors 
in early onset melanoma based on two reasons: 1) skin from the non-whites usually contains 
higher eumelanin levels, which are more protective against UV radiation; 2) while tanning 
bed use is popular in the whites, there is no such popularity in the non-whites, thus it is 
presumed that the often-blamed tanning device use should be excluded from the risks of the 
observed gender difference for early onset melanoma. In order to address these questions 
and provide evidence for our hypothesis, data from the US Surveillance, Epidemiology, and 
End Results (SEER) Program, National Cancer Institute were used to analyze the incidence 
rate and rate ratio by age in the non-Hispanic blacks, Hispanics, Asians/Pacific Islanders, 
and American Indians/Alaska Natives. Furthermore, data from the Cancer Incidence in Five 
Continents, International Agency for Research on Cancer (IARC)/World Health 
Organization were used to validate the SEER findings.
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The intrinsic sex impact on melanoma development has been understudied because in the 
past, most of the sex disparity of melanoma incidence rates at younger age was attributed to 
differential artificial and solar UV exposure [15–18]. Therefore the emphasis for prevention 
and molecular studies has been focused on UV effect. This is partially due to the early 
incorrect conclusion that estrogen receptors were absent in melanoma[19]. All three 
estrogen receptors (ERα, ERβ and GPER1) were recently reported in melanoma tissues and 
cell lines [20–23]. These results provide molecular and cellular supports for our 
epidemiological observations, in which the female sex is independent of UV radiation and 
serves as a risk factor at younger age [24]. Naturally the high estrogen levels in pre-
menopausal women become potential driving forces for melanoma. Our previous studies 
showed that the female to male rate ratios approach 1 around 45–54 years of age [14], which 
is approximate age for menopause in women in the US [25]. Therefore young or old ages in 
this study refer to ages younger or older than this menopause approximated-age. This study 
aims to show that the melanoma incidence rates are also higher in young women as 
compared to young men in non-white ethnic groups, thus potentially excluding the indoor 
tanning bed use as a major attributor for the observed sex difference at young ages.
Our results may open discussions in melanoma research field on non-UV risk factors, thus 
novel prevention strategies can be initiated. As large effort of public education on sunscreen 
use has been in place for many years, the incidence rate of melanoma continues to increase. 
The understudied non-UV risk factors may therefore be an explanation for the observed 
ineffectiveness of sun protection behaviors.
Materials and methods
Study population
SEER13 database (Incidence - SEER13 Regs Research Data + Hurricane Katrina Impacted 
Louisiana Cases, Nov 2016 Sub (1992–2014) <Katrina/Rita Population Adjustment>) was 
downloaded through SEER*Stat software (version 8.3.4). Melanoma cases were collected 
from 13 SEER registries, including San Francisco-Oakland SMSA, Connecticut, Detroit 
(Metropolitan), Hawaii, Iowa, New Mexico, Seattle (Puget Sound), Utah, Atlanta 
(Metropolitan), San Jose-Monterey, Los Angeles, Alaska Natives, and Rural Georgia. 
Melanoma cases from 5 new registries collected between the year 2000 and 2014 in the 
SEER18 database, including California (excluding SF/SJM/LA), Kentucky, Louisiana, New 
Jersey, and Greater Georgia were combined with SEER13 data. Non-Hispanic black (B, 
n=1,533), Hispanic (Spanish-Hispanic-Latino, n=9,122), non-Hispanic Asian or Pacific 
Islander (API, n=1,968), and non-Hispanic American Indian or Alaska Native (AI, n=585) 
melanoma cases were included in this study.
The Cancer Incidence in Five Continents database (CI5) is the result of a long collaboration 
between the International Agency for Research on Cancer (IARC)/World Health 
Organization and the International Association of Cancer Registries. The CI5-Plus (1978–
2007) database, which contains updated annual incidence rates for 118 selected populations 
from 102 cancer registries published in CI5 volumes I to X, was downloaded for analysis to 
validate the findings from SEER. Cancer cases from registries of the US SEER were 
excluded (registry codes 84001-84099). Black (registry code 80002 “Uganda”, n=90), 
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Hispanic (registry codes 7602 “Brazil”, 17001 ”Colombia”, 18800 “Costa Rica”, 21801 
“Ecuador”, 72410, 72404, 72406, 72407, 72408, 72410, 72413 “Spain”, n=10,645), and 
Asian (registry codes 35064, 35606, 35607 “India”, 39203, 39204, 39206 “Japan”, 60801 
“Philippines”, 70200 “Singapore”, 76401, 76404, 76405 “Thailand”, n=4,491, no melanoma 
cases documented in China registries up to 2007) melanoma cases were included for 
validation analysis.
Definition of melanoma
Melanoma was defined in the SEER database based on the Site Recode ICD-O-3/WHO 
2008 as “Melanoma of the skin”, and having AYA site recode/WHO 2008 category “7.1 
Melanoma”. The Primary Sites “C00.0-C80.9” were all included. ICD-O-3 Hist/behave, 
malignant categories of invasive melanoma “8720/3-8723/3, 8726/3, 8727/3, 8730/3, 
8740/3-8746/3, 8761/3, 8770/3-8774/3, and 8780/3” were included, with exclusion of those 
in situ and non-cutaneous morphologies. Malignant melanoma was defined as “C43 
Melanoma of the skin” using the ICD-10 site code in the CI5 database with exclusion of in 
situ melanomas, as well as having the cancer code of “65 Melanoma of the skin”. Therefore, 
melanoma in this study refers to invasive malignant melanoma and does not include in situ 
melanoma.
Statistics
Age-adjusted incidence per 100,000 person-years was derived using US 2000 Census 
Standard Population in 19 five-year age groups (0, 0–4, 5–9,…, 80–84, and 85+) in SEER 
[26], and using World (WHO 2000–2025) Standard Million in 19 age groups in CI5. All 
further analysis and data management were carried out in RStudio (version 3.2.2), Stata or 
Microsoft Excel 2010, if not specified. Incidence rate ratio was calculated using female age-
specific incidence rate divided by male age-specific incidence rate. The 95% confidence 
intervals of rate ratios were calculated by Stata software using standard errors calculated 
from natural log rate ratios [27]. The p-value of trend for rate ratio change over different 
time period was calculated by chi-square test for trend according to the Cochran-Armitage 
method [28].
Results
Patient characteristics
Cancer cases of all causes documented in the SEER13 database (1992–2014), as well as the 
5 new registries in the SEER18 database (2000–2014), encompassed approximately 27.8% 
of the entire US population [29]. Melanoma cases extracted from SEER13 and 18 databases 
included 1,533 (12%) non-Hispanic blacks, 9,122 (69%) Hispanics, 1,968 (15%) non-
Hispanic Asians or Pacific Islanders, and 585 (4%) non-Hispanic American Indians or 
Alaska Natives (Table 1).
The Cancer Incidence in Five Continents database (CI5-Plus, 1978–2007), downloaded from 
the International Agency for Research on Cancer (IARC), World Health Organization, 
included 90 (0.6%) black melanoma cases extracted from the Uganda registry, 10,645 (70%) 
Hispanic cases extracted from the Brazil, Colombia, Costa Rica, Ecuador, and the Spain 
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registries, and 4,491 (29%) Asian cases extracted from the India, Japan, Philippines, 
Singapore, and the Thailand registries. In both the SEER and CI5 databases, the female case 
numbers are higher than the case numbers of the male.
Age-specific incidence rate patterns
In both the SEER and CI5 databases, the age-adjusted incidence per 100,000 person-years of 
all ages shows that men have a higher overall incidence rate as compared to women in the 
Asian or Pacific Islander and the American Indian or Alaska Native populations. However, 
in the non-Hispanic black (black for short) and Hispanic groups, women have overall higher 
incidence rates than men (Table 2).
As reported before, melanoma incidence rates increase with age, with age > 50 years 
showing higher incidence rates than younger age in almost all ethnic groups (Fig. 1A–1F). 
One exception is that the highest age-specific rate is found in the group of 80–84 years in the 
Hispanic males and the American Indians or Alaska Natives (both male and females) (Fig. 
1B, 1D). The oldest group (85+ group) in fact shows a slightly decreased rate (Fig. 1B, 1D). 
Among the ethnic groups in the CI5 database, the highest age-specific incidence rate is 
observed in the oldest men (85+ group).
In the SEER database, black women show higher incidence rates at the age of 15–49 years. 
No incidence was reported before age 15. Men, on the other hand, exhibit higher risk after 
age 50. In the Hispanics, women exhibit higher incidence rates when younger than 59 years, 
and men present higher risks after age 60 (Fig. 1B). A similar trend is also observed in the 
Asian or Pacific Islander (Fig. 1C) and the American Indian or Alaska Native groups (Fig. 
1D). Higher incidence rates are found between the age of 20 to 54 years in the females, and 
the trend reverses after age 55, with males showing higher incidence rates in the Asian or 
Pacific Islander group. However, among American Indians or Alaska Natives, women show 
higher rates at the age of 20–44 years, while men show higher incidences after age 45.
Age-specific incidence rate ratio pattern
Age- and gender-specific incidence RRs were calculated and listed in Table 3. A higher risk 
of melanoma is evident in younger women in the non-Hispanic blacks, Hispanics, Asians or 
Pacific Islanders, and the American Indians or Alaska Natives in the SEER database (Table 
3). The highest female to male RRs are 3.85 (95% CI 1.04–21.2), 2.51 (95% CI 1.11–6.19), 
and 4.36 (95% CI 0.87–42.2, not significant) at the 20–24 age group in the non-Hispanic 
blacks, Asians or Pacific Islanders, and the American Indians or Alaska Natives, 
respectively, similar to what was observed in the white population [14]. Overall the pooled 
population showed RR of 2.67 (2.17–3.30) at 20–24 years of age category (Table 3). Men 
present higher incidence rates of melanoma after age 60 in all four ethnic groups.
In the CI5 database, the case numbers for blacks are too small when stratified by age and sex 
(each age group has less than 10 cases and many groups have 0 cases), and thus blacks are 
excluded for further age-specific rate ratio analysis.
In accordance with what we have found in the US SEER database, the Hispanics (Fig. 1E) 
and the Asians (Fig. 1F) in the CI5 database show similar trend to the SEER results, in 
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which younger Hispanic women (< 55 years) and younger Asian women (< 40 years) exhibit 
higher incidence rates than men, whereas men have higher risks of melanoma at older ages.
Again, the age-specific female to male incidence rate ratios were calculated and listed in 
Table 4. The Hispanic females start to show a higher rate ratio of 1.81 (95% CI 1.18–2.81) at 
the age of 15–19 years up until the age of 45–49 years (RR=1.23, 95% CI 1.07–1.41), 
similar to the trend observed in the Hispanic population documented in the US SEER 
database (Table 3). The highest rate ratio of 1.81 (95% CI 1.18–2.81) is found in the 15–19 
age group (Table 4), somewhat deviating from 25–29 age group in the US SEER Hispanic 
population where the rate ratio is the highest at 3.31 (95% CI 2.59–4.25) (Table 3). 
Incidence rates in the Hispanic men exceed that in women after age 55, comparable to age 
60 in the US SEER data. In the Southeast Asia, females under age 39 exhibit higher risk of 
melanoma than males and males tend to have a higher risk of melanoma after age 40 (Table 
4). The significance levels are compromised in most of the young age group as the RR 
intervals containing 1, except for age group 30–34 (RR=1.44, 95% CI 1.04–2.00). The 
highest rate ratio was observed at the youngest age categories with non-significant 95% 
confidence intervals (0–4 and 5–9, Table 4).
As shown in Fig. 2, age-specific incidence rate ratios were plotted for both the US SEER 
(Fig. 2A) and WHO CI5 (Fig. 2B) databases. Younger women across all races show higher 
incidence than men in the same age range, with a female to male rate ratio greater than 1. In 
contrast, older men (> 60 years) of all races show higher incidence rates than women in the 
same age range, with a rate ratio less than 1. Data from the US SEER and WHO CI5 show 
similar trends, but the difference is manifested at slightly different levels, with CI5 data 
showing lower rate ratios (i.e. showing less gender differences) than the US SEER data. 
Overall, the same gender difference pattern is observed across all races between the two 
databases.
UV is the most important environmental risk factor for melanoma. In order to examine 
whether geographical UV radiation impacts the female to male rate ratios, we separated the 
US SEER registries by latitude of 40°N, resulting in two strata: South (California, Utah, 
New Mexico, Louisiana, Georgia, and Kentucky and Hawaii) and North (Alaska, 
Washington, Iowa, Illinois, Connecticut, and New Jersey). The North and South Age-
specific melanoma rate ratios were calculated and plotted in Fig. 2C. Overall the rate ratio 
patterns are similar in North and South; incidence rates are higher in young women than in 
young men. The peak difference shows a slight age shift: peak at 20–24 in the North group 
and 25–29 in the South group.
In order to examine whether this gender ratio changes over time, we combined all non-white 
populations for every 8-year period in the US SEER data, namely years 1992–1999, 2000–
2007, and 2008–2014 (the last period only contains 7 years of data) (Fig. 2D). Over these 
different periods of time, there are the same patterns of the female to male rate ratio, in 
which females show higher incidence rates at younger age and lower rates at older age as 
compared to males. The peak difference is at age 20–24 for all three periods, exactly as we 
reported before in the Caucasian population [14]. When we selectively examined the 20–24 
years age group, it is quite interesting that the female/male rate ratios increased over the 
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time, from 1.99 (95% 1.71–2.31) in 1992–1999, to 2.17 (95% CI 1.90–2.50) in 2000–2007, 
and 2.74 (95% CI 2.34–3.23) in 2008 to 2014 (Fig. 2E). The trend of ratio increase is 
significant (pTrend =0.0058).
Discussion
In this cancer registry-based study, we show that there is a coherent age-dependent gender 
difference in the risk of melanoma across all ethnic groups. Specifically, in the SEER 
database, black women under the age of 50 exhibit higher incidence rates of cutaneous 
melanoma; above that age women showed lower incidence rates. The switching age is 60 in 
the Hispanics, 55 in the Asians, and 45 in the American Indians. In the WHO CI5 database, 
Hispanics women under age 55 and Asian women under age 40 have higher incidence rates 
of cutaneous melanoma. Men over the age of 60 years, in general, unanimously exhibit 
higher risk for melanoma than the same age range women in the above mentioned ethnic 
groups. The switching age shows a slight shift among these populations. The female to male 
rate ratios also vary from slightly over 1 to nearly 4 (with significant 95% confidence 
intervals, Tables 3, Table 4, and Fig. 2). The highest age-specific female to male incidence 
rate ratios in the SEER database are found in the 20–24 years age group in the blacks, 
Asians, and American Indians, and 25–29 years in the Hispanics. In the WHO CI5 database, 
Asians also show general higher female to male rate ratios at the reproductive age but the 
trend is less consistent. The highest rate ratio is observed at 0–4 (RR = 2.92, 95% CI 0.87–
12.59) and 5–9 (RR=1.70, 95% CI 0.49–6.59); neither reached significance level of 0.05. In 
the WHO CI5 Hispanics population, the highest age-specific female to male incidence rate 
ratios (RR=1.81, 95% CI 1.18–2.81) are observed in the 15–19 years pubescent age group, 
similar to that in the SEER dataset. Previously this gender difference pattern was reported in 
the Caucasian population [11, 14]. Now we demonstrate that the age-dependent gender 
differences in melanoma risk are shared across ethnic groups, which may suggest gender as 
one of the melanoma risk factors in addition to the traditional UV radiation.
The higher incidence rates in younger females in the Caucasians have been speculated to be 
associated with their life style and tanning bed use [30, 31]. In other words, women of the 
younger age are less covered in the sun and use tanning devices more frequently [31, 32]; 
hence they are more exposed to solar and/or artificial UV radiation. Ultimately, UV radiation 
is assumed responsibility for the gender difference at younger age. However, it was reported 
that indoor tanning only accounted for 2.6–9.4% of melanoma incidence [17] and the overall 
UV radiation contribution was approximately 50% to melanoma etiology [33]. Also, females 
are reported to use more sun protection strategies than males [34, 35]. Therefore, the life 
style and UV device use do not seem to completely explain the over 2 fold of incidence rate 
ratio (female/male) in the peak age (20–24 years) in the Caucasians [14]. Our previous 
results have demonstrated that the female sex is independent of ambient UV radiation as a 
risk factor for early-onset melanoma [24]. However, the tanning device use may still be a 
confounder for the female sex. We could not rule out the alternative explanation from 
tanning device use for the higher incidence of early-onset melanoma in women. Tanning 
device use is a habit for the white population as tan skin color is considered fashionable and 
desired. On the other hand, despite the possibility of tanning among some non-white 
populations, such behavior might be unpopular in these ethnicity groups. Findings from the 
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present study reveal that darker skinned females under the age of 40–55 still have higher risk 
of melanoma than their male peers, indicates that tanning device use may not be a common 
determinant for the observed higher risk of early-onset melanoma in women.
A better health consciousness in younger women may be a partial reason for the observed 
gender differences due to early detection that explains the higher incidence in this age range. 
In a retrospective case-control study in the non-Hispanic whites, it was found that women 
were more likely to notice melanomas on their partners, as well as to their own bodies 
compared with men [36]. This resulted in women having statistically significant smaller and 
thinner melanomas and better outcomes than men. Women at all ages also showed fewer 
melanoma metastases and fewer melanoma-related deaths than men. In addition, a survey 
conducted in Texas found that women were more likely to limit outdoor activity, and seek 
shade when being outdoors as compared to men [37]. Socioeconomic factors such as 
income, educational level, and access to healthcare might be the background determinants in 
shaping the health consciousness [38]. How socioeconomic factors contribute to the 
observed sex difference in incidence rates requires further exploration.
A pathophysiological factor may provide an alternative explanation for the observed gender 
differences. Melanoma is the most frequently diagnosed cancer during pregnancy and also in 
the 25–29 age group [39]. It is well documented that pregnancy impacts cutaneous 
melanocyte homeostasis [40]. In our recent study, cutaneous melanoma cases from 31 
European cancer registries and SEER18 database were extracted and correlated to 
geographical UV radiation [11]. Results showed that local ambient UV differentially 
affected cutaneous melanoma incidence rates between genders. No correlation between 
female cutaneous melanoma incidence rates and UV index was found, but men showed a 
significant correlation to ambient UV index [11]. Assuming the female sex exhibits a 
significant impact on early-onset melanoma risk, the lack of significant association between 
female rates and ambient UV index can be explained. The current study provides further 
evidence that it may be the female sex itself that promotes melanoma risk under the age of 
50, although indirect.
On the other hand, old men show higher incidence rates than old women in almost all 
ethnicity groups. In the US, men not only show overall higher melanoma incidence than 
women, they also show worse outcome [41]. The precise reason is not fully understood, but 
it is known that men use less sun protection and thus are likely to accumulative more UV 
damage at older age [42]. If our hypothesis of hormonal regulation is correct, the sharp 
decrease of testosterone levels and/or increase of estrogen levels at older age in men may 
also contribute to melanoma risk.
Recent publications suggested possible roles of estrogen and its receptors in melanoma 
etiology [20, 43, 44]. Estrogen can potentially induce melanocyte growth during pregnancy 
[45]. Although expression of estrogen receptors was found in melanoma cells, different 
subtypes (namely, ERα, ERβ and GPER1) may exhibit different function [20]. Genetic 
variations in ESR1 (ERα) were found to impact melanoma risk [46]. However, overall the 
role of estrogen in melanoma risk remains to be further elucidated. Through our current 
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study we hope to confirm an independent role of sex in melanoma development, which will 
help to build a base for further investigations on sex hormones and melanoma.
As shown in Table 2, the absolute age-adjusted incidence rates in the SEER database are 
much lower than the corresponding rates in CI5 for all races. In the CI5 database, the 
number of black cases is small because the only available source was the Uganda registry. 
The higher rate in this population may be associated with its high average annual UV index 
(UVI=11–12, higher than annual average UVI of 10 in Hawaii). Hispanic is a mixed heritage 
with much heterogeneity of skin color and genetic background. Their skin color can range 
from light (the “white Hispanics” [47]) to dark shades. It is unclear whether the Hispanics 
from CI5 datasets are “whiter” than their peers in the US; the dramatic difference of 
melanoma incidence in these two datasets for Hispanics may provide a good model for 
genetic epidemiological research and warrant further investigation [48]. As for the different 
rates in the two datasets for Asian population, we also do not understand the underlying 
reasons, but it is known that the cancer incidence patterns in immigrants change after the 
first generation, presumably due to the diet and environmental changes [49].
To conclude, age-dependent gender differences in the incidence rates of melanoma are 
observed in all ethnic groups and both datasets. Younger women at pubescent and 
reproductive ages show higher risks than men in the same age range, while older men exhibit 
a higher risk than their women peers. The switching age is close to women’s menopause 
period (i.e. 40–55 years), suggesting a hormonal effect. These new findings may provide a 
base for promoting additional prevention strategies. The role of gender in melanoma risk and 
the underlying mechanisms warrant further investigation.
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Fig. 1. Age-specific incidence rates of melanoma by gender
A. Non-Hispanic blacks (SEER data); B. Hispanics (SEER data); C. Asians or Pacific 
Islanders (SEER data); D. American Indians or Alaska Natives (SEER data); E. Hispanics 
(CI5 data); F. Asians (CI5 data).
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Fig. 2. Age-specific female to male incidence rate ratios by race, age and years of diagnosis
A. SEER data by race and age; B. CI5 data by race and age; C. SEER data with all races 
stratified by geographical location (South and North is divided by latitude of 40°N); D, 
SEER data with all races stratified by diagnosis years. E, the trend of female to male rate 
ratio at 20–24 years of age in different period of time. Thick black horizontal line: RR=1.
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Table 1
Cutaneous melanoma patient characteristics of the SEER and CI5 databases.
Registry SEER IARC/WHO CI5-Plusa
Year 1992–2014 1978–2007
Melanoma (N, Total) 13,208 15,226
Sex
Male (%) 5,953 (45%) 7,271 (48%)
Female (%) 7,255 (55%) 7,973 (52%)
Ethnicity
Black (%) 1,533 (12%) 90 (0.6%)b
Hispanic (%) 9,122 (69%) 10,645 (70%)c
Asian or Pacific Islander (%) 1,968 (15%) 4,491 (29%)d
American Indian or Alaska Native (%) 585 (4%) N/A
Age
Mean 56 58
Standard deviation 59 60
Median 57 57
a
Excluding melanoma cases from the US SEER registries.
bSource available only from the Uganda registry.
c
Including registries from Brazil, Colombia, Costa Rica, Ecuador, and Spain.
d
Including registries from India, Japan, Philippines, Singapore, and Thailand.
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Table 2
Summary of the SEER and CI5 data.
SEERa CI5b
Male Female Male Female
No. of melanoma in study (%) 5,953 (45%) 7,255 (55%) 7,271 (48%) 7,973 (52%)
Age-adjusted incidence per 100,000 person-years of all ages
 Black 2.27 1.81 13.05 22.46
 Hispanic 8.49 7.99 69.96 72.08
 Asian or Pacific Islander 2.24 1.75 9.07 7.44
 American Indian or Alaska Native 6.74 4.79 N/A N/A
aAge-adjusted incidence per 100,000 person-years was done by using US 2000 Census Standard Population in 19 age groups in SEER.
bAge-adjusted incidence per 100,000 person-years was done by using World (WHO 2000–2025) Standard Million in 19 age groups in CI5.
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